Free Trial

MacroGenics (MGNX) Insider Trading & Ownership

MacroGenics logo
$3.52 +0.12 (+3.53%)
(As of 12:56 PM ET)

MacroGenics (NASDAQ:MGNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1.63 M
Get MGNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MacroGenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MGNX Insider Buying and Selling by Quarter

MacroGenics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/4/2024Jeffrey Stuart PetersVPSell51,395$15.55$799,192.25  
2/26/2024Jeffrey Stuart PetersVPSell16,124$17.22$277,655.28  
2/1/2024Ezio BonviniSVPSell13,316$15.00$199,740.00  
1/19/2024Ezio BonviniSVPSell13,316$12.00$159,792.00  
12/20/2023Ezio BonviniSVPSell18,880$10.08$190,310.40  
(Data available from 1/1/2013 forward)

MGNX Insider Trading Activity - Frequently Asked Questions

The list of insiders at MacroGenics includes Edward Hurwitz, Ezio Bonvini, James Karrels, Jeffrey Stuart Peters, and Target N V Biotech. Learn more on insiders at MGNX.

11.30% of MacroGenics stock is owned by insiders. Learn more on MGNX's insider holdings.

The following insiders have purchased MGNX shares in the last 24 months: Edward Hurwitz ($73,650.00), and Target N V Biotech ($7,349,000.00).

Insiders have purchased a total of 1,415,000 MGNX shares in the last 24 months for a total of $7,422,650.00 bought.

The following insiders have sold MGNX shares in the last 24 months: Ezio Bonvini ($549,842.40), and Jeffrey Stuart Peters ($1,109,240.69).

Insiders have sold a total of 118,403 MacroGenics shares in the last 24 months for a total of $1,659,083.09 sold.

MacroGenics Key Executives

  • Dr. Scott Koenig M.D. (Age 72)
    Ph.D., President, CEO & Director
    Compensation: $1.2M
  • Mr. James KarrelsMr. James Karrels (Age 57)
    Senior VP, CFO & Corporate Secretary
    Compensation: $693.31k
  • Dr. Stephen L. Eck M.D. (Age 69)
    Ph.D., Senior VP of Clinical Development & Chief Medical Officer
    Compensation: $766.85k
  • Mr. Eric Blasius Risser (Age 51)
    Chief Operating Officer
    Compensation: $651.36k
  • Dr. Thomas M. Spitznagel Ph.D. (Age 57)
    Senior Vice President of Technical Operations
    Compensation: $550.97k
  • Dr. Ezio Bonvini M.D. (Age 70)
    Senior VP of Research & Chief Scientific Officer
    Compensation: $612.21k
  • Mr. Jeffrey Stuart Peters (Age 53)
    Senior VP, General Counsel & Corporate Compliance Officer
  • Ms. Lynn Cilinski (Age 66)
    VP, Controller & Treasurer


This page (NASDAQ:MGNX) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners